Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Nov 21, 2023

BUY
$0.64 - $1.03 $25,231 - $40,606
39,424 New
39,424 $31,000
Q2 2023

Aug 10, 2023

BUY
$0.64 - $1.03 $25,231 - $40,606
39,424 New
39,424 $31,000
Q1 2023

Nov 21, 2023

BUY
$0.46 - $0.77 $18,135 - $30,356
39,424 New
39,424 $27,000
Q4 2022

Feb 13, 2023

BUY
$0.51 - $17.1 $5,069 - $169,974
9,940 Added 33.71%
39,424 $27,000
Q3 2022

Nov 14, 2022

BUY
$1.01 - $17.0 $29,778 - $501,228
29,484 New
29,484 $45,000
Q4 2021

Feb 08, 2022

SELL
$4.27 - $6.97 $853 - $1,394
-200 Reduced 0.67%
29,584 $154,000
Q3 2021

Nov 12, 2021

SELL
$5.31 - $8.25 $5,283 - $8,208
-995 Reduced 3.23%
29,784 $174,000
Q2 2021

Aug 16, 2021

BUY
$6.81 - $9.23 $681 - $923
100 Added 0.33%
30,779 $248,000
Q1 2021

May 12, 2021

SELL
$7.99 - $15.0 $21,261 - $39,915
-2,661 Reduced 7.98%
30,679 $255,000
Q4 2020

Feb 12, 2021

SELL
$7.04 - $11.7 $8,039 - $13,361
-1,142 Reduced 3.31%
33,340 $253,000
Q3 2020

Nov 03, 2020

BUY
$9.98 - $18.04 $344,130 - $622,055
34,482 New
34,482 $368,000
Q2 2020

Aug 13, 2020

SELL
$7.49 - $15.16 $304,798 - $616,921
-40,694 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$4.62 - $18.74 $22,522 - $91,357
-4,875 Reduced 10.7%
40,694 $339,000
Q4 2019

Jan 30, 2020

SELL
$14.6 - $18.13 $16,060 - $19,943
-1,100 Reduced 2.36%
45,569 $770,000
Q3 2019

Oct 16, 2019

SELL
$16.62 - $23.92 $19,694 - $28,345
-1,185 Reduced 2.48%
46,669 $867,000
Q2 2019

Jul 31, 2019

SELL
$17.79 - $22.88 $49,473 - $63,629
-2,781 Reduced 5.49%
47,854 $1.1 Million
Q1 2019

May 10, 2019

SELL
$11.76 - $22.15 $11,230 - $21,153
-955 Reduced 1.85%
50,635 $1.06 Million
Q4 2018

Feb 05, 2019

SELL
$10.42 - $21.94 $95,655 - $201,409
-9,180 Reduced 15.11%
51,590 $593,000
Q3 2018

Nov 14, 2018

BUY
$20.4 - $24.6 $4,488 - $5,412
220 Added 0.36%
60,770 $1.4 Million
Q2 2018

Aug 02, 2018

BUY
$19.02 - $24.95 $291,101 - $381,859
15,305 Added 33.83%
60,550 $1.35 Million
Q1 2018

May 17, 2018

SELL
$22.55 - $29.9 $31,908 - $42,308
-1,415 Reduced 3.03%
45,245 $1.03 Million
Q4 2017

Feb 12, 2018

SELL
$18.0 - $30.0 $450 - $750
-25 Reduced 0.05%
46,660 $1.22 Million
Q3 2017

Nov 14, 2017

BUY
$21.1 - $25.15 $985,053 - $1.17 Million
46,685
46,685 $1.05 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $115M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.